Bpifrance SA Long-Term Concentrated

Location: Maisons Alfort, Cedex, France

CIK: 0001731118 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Jul 30, 2021

Total Value: $4.503B (100.0% shares, 0.0% debt)

Holdings (8)

STLA STELLANTIS NV 84.1%

Value $3.788B Shares 192,703,907 Est. Cost $17.68 Unrealized —

— CONSTELLIUM NV 6.9%

Value $311M Shares 16,393,903 Est. Cost $6.99 Unrealized —

FTI TECHNIPFMC PLC 4.9%

Value $222M Shares 24,688,691 Est. Cost $17.41 Unrealized -52.4%

CRTO CRITEO S A 2.7%

Value $123M Shares 2,718,752 Est. Cost $22.72 Unrealized —

— VECTIVBIO HOLDING AG 0.7%

Value $32.72M Shares 2,806,217 Est. Cost $11.66 Unrealized —

— SEQUANS COMMUNICATIONS S A 0.4%

Value $19.87M Shares 3,300,018 Est. Cost $1.45 Unrealized —

— CELLECTIS 0.1%

Value $6.586M Shares 425,726 Est. Cost $18.50 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.0%

Value $777K Shares 4,800 Est. Cost $151.00 Unrealized -19.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STLA	STELLANTIS NV	192,703,907	$3.788B	84.1%	$17.68	—	COM	N82405106
—	CONSTELLIUM NV	16,393,903	$311M	6.9%	$6.99	—	CL A	N22035104
FTI	TECHNIPFMC PLC	24,688,691	$222M	4.9%	$17.41	-52.4%	COM	G87110105
CRTO	CRITEO S A	2,718,752	$123M	2.7%	$22.72	—	SPONS ADS	226718104
—	VECTIVBIO HOLDING AG	2,806,217	$32.72M	0.7%	$11.66	—	COM	H9060V101
—	SEQUANS COMMUNICATIONS S A	3,300,018	$19.87M	0.4%	$1.45	—	SPONS ADS	817323108
—	CELLECTIS	425,726	$6.586M	0.1%	$18.50	—	SPONS ADS	15117k103
CRSP	CRISPR THERAPEUTICS AG	4,800	$777K	0.0%	$151.00	-19.5%	COM	H17182108